|
|
Article: Geron Grants License for Nuclear Transfer Technology to XenoTrans.
- Article from:
- Business Wire
- Article date:
- April 27, 2004
CopyrightCOPYRIGHT 2004 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Health/Medical Writers
BIOWIRE2K
MENLO PARK, Calif.--(BUSINESS WIRE)--April 27, 2004
Geron Corporation (Nasdaq:GERN) announced today that it has entered into a non-exclusive license agreement with XenoTrans, Ltd., under which XenoTrans is granted rights to use Geron's nuclear transfer technology to produce transgenic pigs. XenoTrans' strategy is to produce genetically modified pigs for the purpose of generating organs suitable for transplantation into humans.
XenoTrans is a company created out of the Austin Research Institute, a medical research institute located in Heidelberg, Melbourne, Australia. XenoTrans is led by ...